CHDI Foundation

Chdi-logo

CHDI Foundation is a privately-funded, not-for-profit, biomedical research organization that is exclusively dedicated to rapidly discovering and developing therapies that slow the progression of Huntington's disease. Huntington's disease is a genetic neurodegenerative disorder that affects muscle coordination and leads to cognitive decline and psychiatric problems. The CHDI Foundation aims to address this unmet medical need by taking a collaborative approach to research, working closely with a global network of academic and industrial partners.

Mission and Approach

The mission of the CHDI Foundation is to identify and develop drugs that can slow or halt the progression of Huntington's disease. Its approach is to serve as a collaborative hub that brings together the global research community, sharing resources, data, and technologies to foster innovation and accelerate the development of therapeutic solutions. The foundation operates through a model that emphasizes open access to research findings and tools, aiming to ensure that scientific advancements are shared rapidly and efficiently across the research community.

Research Focus

CHDI Foundation's research encompasses a broad range of scientific disciplines, including molecular biology, biochemistry, genetics, pharmacology, and clinical science. The foundation's strategy involves:

- Understanding the basic biology of Huntington's disease - Identifying and validating therapeutic targets - Developing and optimizing therapeutic compounds - Supporting clinical trials and biomarker studies

One of the key areas of focus is the huntingtin protein, which, when mutated, leads to the development of Huntington's disease. Research efforts aim to understand the precise functions of this protein, how its mutation causes disease, and how to mitigate its harmful effects.

Collaborations and Partnerships

CHDI Foundation actively seeks and establishes collaborations with academic institutions, pharmaceutical and biotechnology companies, and other research organizations. These partnerships are crucial for sharing expertise, resources, and technologies that can accelerate the pace of research and development. The foundation also supports a variety of consortia and networks that foster collaboration and data sharing among researchers.

Funding and Grants

As a not-for-profit organization, CHDI Foundation provides funding for research projects that align with its mission. This includes grants for individual researchers, as well as funding for collaborative projects and infrastructure support for Huntington's disease research. The foundation's funding model is designed to fill gaps in the research landscape, providing resources where they are most needed to advance the field.

Impact

The work of the CHDI Foundation has significantly contributed to the advancement of Huntington's disease research. By fostering collaboration and providing critical funding and resources, the foundation has helped to accelerate the discovery of potential therapeutic targets and the development of new treatment strategies. Its commitment to open science and data sharing has also facilitated progress across the broader scientific community, advancing our understanding of neurodegenerative diseases.

See Also

• Neurodegenerative diseases
• Genetic disorders
• Drug development
• Clinical trials

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian